鸿运华宁（杭州）生物医药有限公司 Hongyun Huaining (Hangzhou) Biomedical Co. LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
The World's First ETa-specific Monoclonal Antibody: Gmax Biopharm's GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease 2022-11-14 22:55
Gmax's GMA106, second generation obesity/T2DM/NASH mAb gives first in human dose 2021-11-11 18:00
GMAX Zhengzhou Manufacturing Site Breaks Ground 2020-12-15 18:00
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial 2020-10-26 18:00
1